FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311849774> ?p ?o ?g. }

• W4311849774 abstract "Objectives: Coronary microembolization (CME) represents a serious periprocedural complication after percutaneous coronary intervention. Ferroptosis has been identified in multiple cardiovascular diseases. In this study, we aimed to investigate the effects of atorvastatin (ATV) on ferroptosis and inflammation following CME and elucidate the underlying mechanism. Methods: We established a rat model of CME by injecting microspheres into the left ventricle. Deferoxamine (DFO), a selective ferroptosis inhibitor, or ATV was pretreated before modeling. Cardiac function and cardiac troponin T (cTnT) levels were detected. Levels of ferroptosis-associated genes, malondialdehyde (MDA), glutathione (GSH), and ferrous iron (Fe 2+ ) were measured to validate ferroptosis. Levels of tumor necrosis factor alpha (TNF-α) and interleukin 1 beta (IL-1β) were assayed to determine the inflammation. Chromatin immunoprecipitation was performed to determine the binding of hypoxia-inducible factor 1 subunit alpha (Hif1a) to the promoter of prostaglandin-endoperoxide synthase-2 (Ptgs2). Results: Ferroptosis and inflammation were induced following CME with increased levels of MDA (∼2.5 fold, p &lt; 0.01), Fe 2+ (∼1.5 fold, p &lt; 0.01), TNF-α, and IL-1β and decreased GSH levels (∼42%, p &lt; 0.01). Meanwhile, the level of Ptgs2 was significantly increased, while those of glutathione peroxidase 4 (Gpx4) and solute carrier family 7 member 11 (Slc7a11) were decreased. The level of cTnT was increased by 7-fold ( p &lt; 0.01). Left ventricular ejection fraction (LVEF) was significantly reduced (∼85% in the sham group versus ∼45% in the CME group, p &lt; 0.01). DFO or Ptgs2 silencing inhibited the increase of MDA, Ptgs2, TNF-α, and IL-1β, and induced the levels of GSH and Gpx4, followed by reduction in cTnT levels by approximately 50% ( p &lt; 0.01). LVEF was improved by approximately 2 fold ( p &lt; 0.01). Mechanistically, the transcription factor Hif1a bound to the promoter of Ptgs2 and upregulated its expression. In addition, ATV inhibited the activation of the Hif1a/Ptgs2 axis and attenuated cardiac ferroptosis and inflammation, thus ameliorating CME-induced myocardial injury (LVEF, ∼34% elevation; cTnT, ∼1.8 fold decrease, p &lt; 0.01). Conclusion: Atorvastatin ameliorates ferroptosis-mediated myocardial injury and inflammation following CME via the Hif1a/Ptgs2 pathway." @default.
• W4311849774 created "2023-01-01" @default.
• W4311849774 creator A5000380008 @default.
• W4311849774 creator A5040091210 @default.
• W4311849774 creator A5041038506 @default.
• W4311849774 creator A5052426057 @default.
• W4311849774 creator A5075088229 @default.
• W4311849774 creator A5086326013 @default.
• W4311849774 creator A5089574305 @default.
• W4311849774 date "2022-12-08" @default.
• W4311849774 modified "2023-10-14" @default.
• W4311849774 title "Atorvastatin attenuates ferroptosis-dependent myocardial injury and inflammation following coronary microembolization via the Hif1a/Ptgs2 pathway" @default.
• W4311849774 cites W1969100490 @default.
• W4311849774 cites W2024774657 @default.
• W4311849774 cites W2026818910 @default.
• W4311849774 cites W2056008671 @default.
• W4311849774 cites W2080274549 @default.
• W4311849774 cites W2080276645 @default.
• W4311849774 cites W2089090286 @default.
• W4311849774 cites W2089692434 @default.
• W4311849774 cites W2109215342 @default.
• W4311849774 cites W2114532627 @default.
• W4311849774 cites W2134966197 @default.
• W4311849774 cites W2160875888 @default.
• W4311849774 cites W2161238300 @default.
• W4311849774 cites W2168338299 @default.
• W4311849774 cites W2570787279 @default.
• W4311849774 cites W2767490296 @default.
• W4311849774 cites W2790531075 @default.
• W4311849774 cites W2891678790 @default.
• W4311849774 cites W2911996561 @default.
• W4311849774 cites W2914574872 @default.
• W4311849774 cites W2916144846 @default.
• W4311849774 cites W2971367862 @default.
• W4311849774 cites W2974853861 @default.
• W4311849774 cites W2988716798 @default.
• W4311849774 cites W3013314180 @default.
• W4311849774 cites W3013967177 @default.
• W4311849774 cites W3020890805 @default.
• W4311849774 cites W3095680891 @default.
• W4311849774 cites W3108493784 @default.
• W4311849774 cites W3118563385 @default.
• W4311849774 cites W3168132945 @default.
• W4311849774 cites W3191791892 @default.
• W4311849774 cites W3197233987 @default.
• W4311849774 cites W3204982646 @default.
• W4311849774 cites W3214698516 @default.
• W4311849774 cites W4283795391 @default.
• W4311849774 cites W4284889683 @default.
• W4311849774 doi "https://doi.org/10.3389/fphar.2022.1057583" @default.
• W4311849774 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36569299" @default.
• W4311849774 hasPublicationYear "2022" @default.
• W4311849774 type Work @default.
• W4311849774 citedByCount "4" @default.
• W4311849774 countsByYear W43118497742023 @default.
• W4311849774 crossrefType "journal-article" @default.
• W4311849774 hasAuthorship W4311849774A5000380008 @default.
• W4311849774 hasAuthorship W4311849774A5040091210 @default.
• W4311849774 hasAuthorship W4311849774A5041038506 @default.
• W4311849774 hasAuthorship W4311849774A5052426057 @default.
• W4311849774 hasAuthorship W4311849774A5075088229 @default.
• W4311849774 hasAuthorship W4311849774A5086326013 @default.
• W4311849774 hasAuthorship W4311849774A5089574305 @default.
• W4311849774 hasBestOaLocation W43118497741 @default.
• W4311849774 hasConcept C111566952 @default.
• W4311849774 hasConcept C126322002 @default.
• W4311849774 hasConcept C134018914 @default.
• W4311849774 hasConcept C17991360 @default.
• W4311849774 hasConcept C2776151105 @default.
• W4311849774 hasConcept C2776914184 @default.
• W4311849774 hasConcept C2778198053 @default.
• W4311849774 hasConcept C2778401633 @default.
• W4311849774 hasConcept C71924100 @default.
• W4311849774 hasConcept C78085059 @default.
• W4311849774 hasConcept C98274493 @default.
• W4311849774 hasConceptScore W4311849774C111566952 @default.
• W4311849774 hasConceptScore W4311849774C126322002 @default.
• W4311849774 hasConceptScore W4311849774C134018914 @default.
• W4311849774 hasConceptScore W4311849774C17991360 @default.
• W4311849774 hasConceptScore W4311849774C2776151105 @default.
• W4311849774 hasConceptScore W4311849774C2776914184 @default.
• W4311849774 hasConceptScore W4311849774C2778198053 @default.
• W4311849774 hasConceptScore W4311849774C2778401633 @default.
• W4311849774 hasConceptScore W4311849774C71924100 @default.
• W4311849774 hasConceptScore W4311849774C78085059 @default.
• W4311849774 hasConceptScore W4311849774C98274493 @default.
• W4311849774 hasFunder F4320321001 @default.
• W4311849774 hasLocation W43118497741 @default.
• W4311849774 hasLocation W43118497742 @default.
• W4311849774 hasLocation W43118497743 @default.
• W4311849774 hasLocation W43118497744 @default.
• W4311849774 hasOpenAccess W4311849774 @default.
• W4311849774 hasPrimaryLocation W43118497741 @default.
• W4311849774 hasRelatedWork W1966504330 @default.
• W4311849774 hasRelatedWork W1977918131 @default.
• W4311849774 hasRelatedWork W1979139803 @default.
• W4311849774 hasRelatedWork W1990717759 @default.
• W4311849774 hasRelatedWork W2030889776 @default.
• W4311849774 hasRelatedWork W2037631372 @default.
• W4311849774 hasRelatedWork W2040058909 @default.

• next